Community · single experiences
Effect Profile
Describes the acute effect. This profile does not influence the OpenMind Score.
No effect profiles yet. Describe the acute effect without changing the long-term score.
Please log in to add effect details
Log inDescription
A triple monoamine reuptake inhibitor developed by Hoffman-LaRoche in the 1970s as an antidepressant but discontinued, probably due to high abuse potential. Has not become popular as a recreational drug at this time. Acts as an SNDRI, mostly inhibits dopamine and noradrenaline.
Effects & Dosing
Dosage
Oral
| Threshold | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| 12-15 mg | 30-40 mg | 40-60 mg | - | 60-80 mg |
Duration
Oral
Total Duration 4h - 6h
Safety & Risks
Safer Use
- NOTE: These doses are tentative and may need further research.
Community Experiences
Share a single experience — does not affect the OpenMind Score.
Comments
Please log in to comment
Log inPlease sign in to suggest edits.
Everything in OpenMind
Track your use, check combinations and find safer use tips – even offline.
No comments yet.